Cited by 65Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue

Open access
Rathi, Abhijit, Jadhav, Swati B., Shah, Neha·2021·Medicines

Abstract

Muscle fatigue and cognitive disturbances persist in patients after recovery from acute COVID-19 disease. However, there are no specific treatments for post-COVID fatigue. Objective: To evaluate the efficacy and safety of the health supplements ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (probiotic complex) in patients suffering from COVID-19 induced fatigue. A randomized, multicentric, double blind, placebo-controlled trial was conducted in 200 patients with a complaint of post-COVID fatigue. The test arm (n = 100) received the oral supplements for 14 days and the control arm (n = 100) received a placebo. Treatment efficacy was compared using the Chalder Fatigue scale (CFQ-11), at various time points from days 1 to 14. The supplemental treatment resulted in resolution of fatigue in a greater percentage of subjects in the test vs. the control arm (91% vs. 15%) on day 14. Subjects in the test arm showed a significantly greater reduction in total as well as physical and mental fatigue scores at all time points vs. the control arm. The supplements were well tolerated with no adverse events reported. This study demonstrates that a 14 days supplementation of ImmunoSEB + ProbioSEB CSC3 resolves post-COVID-19 fatigue and can improve patients’ functional status and quality of life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medicines8090047

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a study, 91/100 SARS-CoV-2 patients who received probiotics (Bacillus coagulans, Bacillus subtilis, Bacillus clausii) showed diminished physical and mental fatigue compared with 15/100 placebo patients on day 14.

    “A study by [151] reported improvements in patients who received probiotics and enzyme supplements, as 91/100 patients with SARS-CoV-2 who received the treatment with probiotics (Bacillus coagulans, Bacillus subtilis and Bacillus clausii) showed diminished physical and mental fatigue compared with 15/100 placebo patients on day 14 of the treatment.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [7]Kedor C. Freitag H. Meyer-Arndt L.A. Wittke K. Steinbeis F. Haffke M. Gordon R. Heidecker B. Volk H.D. Skurk C. Chronic COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) following the first pandemic wave in Germany—A first analysis of a prospective observational study medRxiv 2021 10.1101/2021.02.06.21249256 · DOI

Cited by

Sorted by citations

Authors
Rathi, A., Jadhav, S. B., & Shah, N.
Affiliations
  • Advanced Enzyme Technologies Limited (India) (IN)
  • Cystic Fibrosis Canada (CA)
Corresponding author
Rathi, Abhijit
Venue
Medicines
Publisher
MDPI AG
Published
2021-08-30
Volume
8
Issue
9
Pages
47
ISSN
2305-6320 (ISSN-L)
OpenAlex
W3198559038
Cited by
65
References
58
Citations by year
2026: 6 · 2025: 12 · 2024: 25 · 2023: 9 · 2022: 12 · 2021: 1
FWCI
5.62
Type
journal article
Language
en
Open access
Locations
  • Medicines (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
post-COVID-19 fatigue, probiotics, dietary supplements, Chalder Fatigue Questionnaire, physical and mental fatigue, functional status, quality of life, COVID-19 recovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review